TRVI - Trevi Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Trevi Therapeutics, Inc. Common Stock
IPO Date: May 7, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $2.13B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.19 | 4.37%
Avg Daily Range (30 D): $0.46 | 2.58%
Avg Daily Range (90 D): $0.54 | 3.17%
Institutional Daily Volume
Avg Daily Volume: .61M
Avg Daily Volume (30 D): 1.27M
Avg Daily Volume (90 D): 1.57M
Trade Size
Avg Trade Size (Sh.): 127
Avg Trade Size (Sh.) (30 D): 76
Avg Trade Size (Sh.) (90 D): 80
Institutional Trades
Total Institutional Trades: 909
Avg Institutional Trade: $2.02M
Avg Institutional Trade (30 D): $2.94M
Avg Institutional Trade (90 D): $2.93M
Avg Institutional Trade Volume: .21M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.41M
Avg Closing Trade (30 D): $3.61M
Avg Closing Trade (90 D): $3.96M
Avg Closing Volume: 226.45K
 
News
Jul 28, 2026 @ 11:30 AM
Trevi Therapeutics to Participate in Upcoming Augu...
Source: Na
Apr 17, 2026 @ 2:42 AM
Trevi Therapeutics Announces Pricing of $150 Milli...
Source: Na
Apr 17, 2026 @ 2:42 AM
Trevi Therapeutics Announces Pricing of $150 Milli...
Source: Na
Nov 24, 2025 @ 6:00 PM
Chronic Refractory Cough Market is Expected to Boo...
Source: Delveinsight
Jun 26, 2025 @ 11:00 AM
TRVI STOCKHOLDER ALERT: Kaskela Law LLC Announces ...
Source: Kaskela Law Llc
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.11 $-.09
Diluted EPS $-.11 $-.09
Revenue $M $M
Gross Profit
Net Income / Loss $-17.8M $-13.19M
Operating Income / Loss $-20.51M $-14.91M
Cost of Revenue
Net Cash Flow $34.89M $.5M
PE Ratio